Abiopharma

AIM ImmunoTech Releases Virtual Investor What This Means Video Segment Discussing Ampligens Potential in Ebola Virus Disease Preparedness

AIM ImmunoTech Releases Virtual Investor ‘What This Means’ Video Segment Discussing Ampligen’s Potential in Ebola Virus Disease Preparedness

LPL Financial Welcomes Align Private Wealth

Capital market presentation - May 2026

Wearable Devices Announces Pre-Order for Mudra Pro to Fast-Track AI and XR Programs for Enterprise and OEM Customers

Form 4 -STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP - Gilad Yavetz

Change in holdings of interested parties/officers

Perfect Corp. Brings the Bleeding-Edge of AI Innovation to Viva Tech 2026

Change in holdings of interested parties/officers

Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma